Rallybio (RLYB)
(Delayed Data from NSDQ)
$0.53 USD
-0.02 (-3.70%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $0.52 -0.01 (-1.46%) 4:44 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Rallybio Corporation has a market cap of $22.80M, which represents its share price of $0.55 multiplied by its outstanding shares number of 41.61M. As a small-cap company, RLYB's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
RLYB 0.53 -0.02(-3.70%)
Will RLYB be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for RLYB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RLYB
RXRX Stock Up on Acquiring Full Rights to the Hypophosphatasia Program
RLYB Ends Pregnancy-Related Rare Disease Program, Stock Tanks
RLYB: What are Zacks experts saying now?
Zacks Private Portfolio Services
Rallybio (RLYB) Upgraded to Buy: What Does It Mean for the Stock?
Other News for RLYB
12 Health Care Stocks Moving In Monday's After-Market Session
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
12 Health Care Stocks Moving In Tuesday's Intraday Session
Rallybio (RLYB) Shares Soar on Asset Sale to Recursion
Recursion to buy Rallybio’s ownership in jointly developed bone disorder drug